Menard Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.83M Buy
+1,985
New +$2.01M 1.28% 20
2025
Q3
Sell
-851
Closed -$663K 92
2025
Q2
$663K Sell
851
-30
-3% -$23.3K 0.39% 50
2025
Q1
$683K Buy
881
+71
+9% +$59.1K 0.45% 47
2024
Q4
$625K Buy
810
+49
+6% +$40.6K 0.38% 58
2024
Q3
$674K Buy
761
+17
+2% +$15.3K 0.44% 53
2024
Q2
$674K Buy
744
+28
+4% +$22.4K 0.48% 47
2024
Q1
$557K Buy
+716
New +$510K 0.47% 52

Other funds holding LLY

Menard Financial Group's LLY Position: Q1 2026 in Review

Menard Financial Group opened a new position in Eli Lilly (LLY) in Q1 2026: 1,985 shares worth $1.83M. The stake represents 1.28% of the portfolio and ranks #20 among its holdings. This is a return to the name: Menard Financial Group previously reported a position in LLY as recently as Q2 2025.

Menard Financial Group first reported a position in LLY in Q1 2024 and has held it in 7 quarters since. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Menard Financial Group held 1,985 shares of Eli Lilly worth $1.83M as of Q1 2026.
  • Eli Lilly was a new Menard Financial Group position in Q1 2026.
  • Eli Lilly made up 1.28% of Menard Financial Group's portfolio in Q1 2026, its #20 holding.
  • Menard Financial Group first reported a position in Eli Lilly in Q1 2024 and has held it in 7 quarters since.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Menard Financial Group's 13F filing for Q1 2026, filed 14 May 2026.